This is a great thread, thanks D and Worth.The way I read the...

  1. 3 Posts.
    This is a great thread, thanks D and Worth.

    The way I read the GSK reference, ATC is miles ahead...
    Phase III vs Phase II proof of concept, 100+ vs 32 pts, clinical performance better, etc. Yet IDX899 has scored a deal - upfront payment of USD34m with more later - that sounds fantastic to suffering holders of AVX.

    Could this mean Avexa is holding out for some super-deal?

    Any thoughts?

    CG

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.